/
HQL
$19.76+$0.51 (+2.65%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$585.4M
30M shares
52-week range
$12.72 – $19.82
99% from low
Exchange
NYSE
FUND
Price (6 mo)
Loading chart…
Change$-1.68
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.0M | $2.4M | $39.1M | $45.0M | $31.9M | $39.4M | $86.7M | $86.4M |
| Cost of revenue | $0 | $0 | $5.2M | $6.1M | $5.5M | $5.2M | $5.4M | $5.0M |
| Gross profit | $2.0M | $2.4M | $33.9M | $38.9M | $26.3M | $18.3M | $86.7M | $86.4M |
| Gross margin | 100.0% | 100.0% | 86.7% | 86.5% | 82.6% | 46.4% | 100.0% | 100.0% |
| R&D | $0 | $0 | $3 | $0 | −$3 | $0 | $0 | $0 |
| Operating income | −$3.6M | −$2.9M | $123.1M | $64.5M | −$104.6M | −$5.2M | $85.3M | $85.6M |
| EBITDA | $0 | $0 | $123.1M | $68.7M | −$101.6M | $50.0M | $87.2M | $85.6M |
| Net income | $28.7M | −$70.5M | $123.1M | $64.5M | −$104.6M | $22.4M | $85.3M | $85.6M |
| Net margin | 1443.4% | -2887.8% | 314.9% | 143.3% | -328.3% | 56.8% | 98.4% | 99.1% |
| EPS (diluted) | 1.28 | -3.04 | 5.16 | 2.66 | -4.07 | 0.79 | 3.04 | 2.96 |
Annual figures · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$91.42
Price
$19.76
Implied upside
+363%
Peer comparison
abrdn Life Sciences Investors
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.
www.abrdnhql.com- IPO / List date
- May 1, 1992
Held by traders on TradeandTell
No one on the platform currently holds HQL.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in HQL as of their last filing.
Insider activity (SEC Form 4)
Dividend history
TTM yield · 10.32% ($2.04/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-21 | $0.5600 | 2026-06-30 |
| 2026-02-20 | $0.5600 | 2026-03-31 |
| 2025-11-21 | $0.5000 | 2026-01-12 |
| 2025-08-22 | $0.4200 | 2025-09-30 |
| 2025-05-22 | $0.4300 | 2025-06-30 |
| 2025-02-21 | $0.4700 | 2025-03-31 |
| 2024-11-21 | $0.5000 | 2025-01-10 |
| 2024-08-23 | $0.4900 | 2024-09-30 |
| 2024-05-22 | $0.4800 | 2024-06-28 |
| 2024-02-21 | $0.3900 | 2024-03-28 |
Recent trades on TradeandTell
No one on the platform has traded HQL yet.
